Shikonin suppresses colon cancer cell growth and exerts synergistic effects by regulating ADAM17 and the IL-6/STAT3 signaling pathway

Signal transducer and activator of transcription 3 (STAT3) activation is associated with drug resistance induced by anti-epidermal growth factor receptor (anti-EGFR) therapy in the treatment of colon cancer. Thus, the combined inhibition of EGFR and STAT3 may prove beneficial for this type of cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Wei, Men, Lintong, Pi, Xiu, Jiang, Tao, Peng, Dewei, Huo, Shengqi, Luo, Pengcheng, Wang, Moran, Guo, Junyi, Jiang, Yue, Peng, Lulu, Lin, Li, Li, Sheng, Lv, Jiagao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577797/
https://www.ncbi.nlm.nih.gov/pubmed/34726248
http://dx.doi.org/10.3892/ijo.2021.5279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577797/
https://www.ncbi.nlm.nih.gov/pubmed/34726248
http://dx.doi.org/10.3892/ijo.2021.5279

Ejemplares similares